MediSun Technology
Healthy Sun™

MediSun

MediSun Device and Features

The MediSun’s breakthrough patented technology will be available for medically supervised treatment.

The device is engineered with innovative features that are the first of its kind. The device is equipped with safety measures and sensors that ensure proper dosage and preclude over exposure. State of the art LED display and software provide precise dosage inputs and quantity of vitamin D generated from each treatment.

The MediSun’s proprietary and patented design maximizes the amount of vitamin D produced and minimizes treatment times. The device shields the face and provides a body-only treatment without the need to completely enclose the patient in a cabinet. Patient’s body temperature and position are monitored throughout the session to maximize safety and comfort.

The device will be available for both medical office usage as well as home medically supervised usage. It will conveniently fold flat and lock when not in use.

Marketplace

Currently, there is an immense need for the MediSun. Over one hundred million Americans suffer from vitamin D deficiency and over one billion people worldwide. 1 Additionally, vitamin D deficiency has been correlated to such prevalent neurological disorders as Parkinson’s effecting one million Americans, 2 multiple sclerosis effecting two million American’s, 3 and Alzheimer’s effecting over five million people in the U.S. 4 Vitamin D deficiency also greatly effects athletic performance. There are over five million professional athletes in the U.S., over four hundred thousand division one athletes, and it is estimated that each year weekend athletes suffer hundreds of thousands of injuries due to deficiencies such as hypovitaminosis d. Vitamin D has also been proven to aid in the treatment and prevention of Autism which effects one in every 50 children in the U.S., a number which has grown over 78% in the last decade according to the CDC.5

Clinical Trials

The University of Illinois has committed to clinical trials in the fall confirming the potential benefits of UVB phototherapy for treatment and prevention of MS. Recently, UVB phototherapy has been shown to have positive benefits beyond vitamin D that play a role in decreasing disease risk. It has long been known that there is a geographical variance that correlates MS with decreased UVB exposure. This has led researchers to theorize that vitamin D levels may only provide a mechanism of measuring sun exposure. Instead, UVB induced mechanisms rather than vitamin D driven processes may explain many of the benefits often attributed to vitamin D. Sun Health is in the process of submitting a paper for publication in medical journals supporting these theories.

The University Of Illinois has also signed a letter of intent for studies involving post-traumatic stress disorder, concussion and traumatic brain injury – all highly relevant conditions that are currently being looked at in-depth by the military and athletic organizations such as the NFL and NCAA.

Initial devices will be available for institutions around the world that are conducting research into the potential benefits of UVB and vitamin D. Ultimately the devices will be for use by physicians, hospitals, clinics, and in the future for home prescription sales. Additionally, the device will be available for medical expert’s specialized treatment of disease states and psychiatric treatment from ADHD to depression.

References

1 Wacker, M. Effects on skeletal and extra-skeletal health and the need for supplementation. Nutrients. 2013 Jan 10; 5-(1):111-48

2 Parkinson’s Disease Foundation Website www.pdf.org. October, 2013.

3 National MS Society Website www.mssociety.org. October, 2013.

4 National Institute on Aging Website www.nia.gov. October, 2013.

5 Falco, M. CDC: U.S. kids with autism up 78% in past decade. CNN Website. March 29, 2012.

www.sunhealthtech.com